From its proprietary portfolio and its sourcing partners’ portfolios, Midas offers intermediates, drug substances and drug products, as well as licensing opportunities of drug product developments, including:
Intermediates — industrial reactives, fine chemicals, critical and advanced intermediates.
Drug Substances — active pharmaceutical ingredients and biopharmaceutical compounds.
Finished Drug Products — innovative drugs and technologies, generic drugs, and consumer healthcare products.
Medical Devices — autoinjector platform for small molecules and biologic drugs.
Primary Packaging — syringes, vials, cartridges with barrier coating system and glass and plastic bottles, closures and accessories
In addition, we offer complementary services covering all stages of the pharmaceutical value chain to meet the specific needs of our customers and partners.